Heartflow, Inc.
Nasdaq · Surgical & Medical Instruments & Apparatus
Company Overview
A concise company profile alongside the latest public filing activity.
HeartFlow makes software that analyzes CT scans to create personalized 3D models of coronary arteries, helping physicians assess blood flow and diagnose heart disease without invasive testing.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Verghese VikramChief Financial Officer | Sell | $1.49M | 29,714at $50.06 | Sep 11, 2026 |
| Verghese VikramChief Financial Officer | Sell | $231K | 4,593at $50.24 | Sep 14, 2026 |
| Verghese VikramChief Financial Officer | Sell | $33K | 668at $50.01 | Sep 15, 2026 |
| Farquhar John C.M.Chief Executive Officer | Sell | $1.36M | 27,230at $50.00 | Aug 21, 2026 |
| Farquhar John C.M.Chief Executive Officer | Sell | $1.47M | 32,676at $45.00 | Aug 18, 2026 |
| Rogers CampbellChief Medical Officer | Sell | $380K | 9,219at $41.23 | Aug 17, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable HTFL activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.